OUR INVESTMENTS
Developed a clinically-validated system that detects pulmonary abnormalities through a miniaturized skin-worn stethoscope which measures breathing patterns and lung sounds. Based in Philadelphia,PA.
Year Invested: 2019 // Status: Current
Monoclonal antibodies being developed as anti-infective drugs. Based in San Jose, California.
Year Invested: 2017 // Status: Current
Injectable bulking agent therapy for the treatment of GERD. Based in St. Paul, Minnesota.
Year Invested: 2016 // Status: Current
Restoring autonomy in mobility with its lightweight, lower-half-of-the-body walk-assist device. Based in Quebec, Canada.
Year Invested: 2016 // Status: Current
Next generation vaccines for allergy, cancer and infectious disease targets. Based in Hershey, PA.
Year Invested: 2014 // Status: Dividend paid 2016; Exited 2020